Your browser doesn't support javascript.
loading
CIITA-driven MHC class II expressing tumor cells can efficiently prime naive CD4+ TH cells in vivo and vaccinate the host against parental MHC-II-negative tumor cells.
Bou Nasser Eddine, Farah; Forlani, Greta; Lombardo, Letizia; Tedeschi, Alessandra; Tosi, Giovanna; Accolla, Roberto S.
Afiliação
  • Bou Nasser Eddine F; Department of Surgical and Morphological Sciences, School of Medicine, University of Insubria , Varese, Italy.
  • Forlani G; Department of Surgical and Morphological Sciences, School of Medicine, University of Insubria , Varese, Italy.
  • Lombardo L; Department of Surgical and Morphological Sciences, School of Medicine, University of Insubria , Varese, Italy.
  • Tedeschi A; Department of Surgical and Morphological Sciences, School of Medicine, University of Insubria , Varese, Italy.
  • Tosi G; Department of Surgical and Morphological Sciences, School of Medicine, University of Insubria , Varese, Italy.
  • Accolla RS; Department of Surgical and Morphological Sciences, School of Medicine, University of Insubria , Varese, Italy.
Oncoimmunology ; 6(1): e1261777, 2017.
Article em En | MEDLINE | ID: mdl-28197387
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article